Skip to main content
Tech.euFundingExplorerBeta

OutSee

OutSee is a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery.

OutSee has raised €5.0M across 2 funding rounds from 6 investors, most recently a Seed round in Jan 2026. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€5.0M
€4,997,778
Funding rounds
2
Investors
6
distinct backers
Active since
2025-06
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
OutSee — funding by year — interactive chart.
Data table
OutSee — funding by year
2025€2.1M
2026€2.9M

Signals

High confidence
Raise-next likelihood65
base rate 44% for Seed
  • ▲ In typical raise window
  • ▲ Up-round momentum
Exit likelihood12
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Related news

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData